SCHEMBL26034744

SCHEMBL26034744

Cc1ccc(NC(=O)c2ccc(NS(C)(=O)=O)cc2)cc1-c1ccccn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.57
NAMPT P43490 1/20 0.53
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
MAPK14 Q16539 2/20 0.52
CDK9 P50750 1/20 0.52
NPC1 O15118 2/20 0.50
RAB9A P51151 1/20 0.50
ALB P02768 1/20 0.50
HTR1A P08908 1/20 0.50
SLC6A2 P23975 1/20 0.50
PDE4A P27815 1/20 0.50
OPRM1 P35372 1/20 0.50
DRD3 P35462 1/20 0.50
HTR2B P41595 1/20 0.50
SLC6A3 Q01959 1/20 0.50
PDE4D Q08499 1/20 0.50
SHH Q15465 1/20 0.50
USP28 Q96RU2 1/20 0.50
SLC29A1 Q99808 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26037196 0.89 HPGD (0.48) HPGDKMT2AMEN1MAPK14CDK9
SCHEMBL26037289 0.88 MAPK14 (0.48) HPGDKMT2AMAPK14NPC1RAB9A
SCHEMBL2611893 0.88 ALB (0.65) HPGDNAMPTKMT2AMEN1ALB
SCHEMBL26034631 0.86 MAPK14 (0.48) KMT2AMAPK14NPC1RAB9AALB
SCHEMBL26034762 0.86 KMT2A (0.48) KMT2AMEN1MAPK14NPC1RAB9A
SCHEMBL26036139 0.86 CA2 (0.56) KMT2AMEN1MAPK14NPC1RAB9A
SCHEMBL26037383 0.84 DRD3 (0.66) KMT2AMEN1ALBHTR1ASLC6A2
SCHEMBL26035101 0.84 ALB (0.50) KMT2AMAPK14NPC1RAB9AALB
SCHEMBL26037249 0.82 NPC1 (0.50) KMT2AMAPK14NPC1RAB9A
SCHEMBL26037456 0.82 KDM4A (0.50) KMT2AMAPK14NPC1RAB9AALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING SHH, GLI1, SMO HPGD 2728/4885NAMPT 2382/4885KMT2A 1528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.